Page last updated: 2024-08-23

pravastatin and 1-anilino-8-naphthalenesulfonate

pravastatin has been researched along with 1-anilino-8-naphthalenesulfonate in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Emoto, M; Inoue, T; Kawasaki, K; Konishi, T; Morii, H; Nishizawa, Y; Shoji, T; Tabata, T	1
Scheen, AJ	1
García-Iglesias, MF; Laguna, F; Lahoz, C; Mostaza, JM; Peña, R; Pintó, X; Taboada, M	1

Trials

2 trial(s) available for pravastatin and 1-anilino-8-naphthalenesulfonate

Article	Year
Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients. Clinical nephrology, 1995, Volume: 43, Issue:4 Topics: Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Female; Humans; Lipase; Lipoprotein Lipase; Lipoproteins; Lipoproteins, IDL; Liver; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Phosphatidylcholine-Sterol O-Acyltransferase; Pravastatin; Renal Dialysis; Triglycerides; Uremia	1995
The -514C/T polymorphism of the hepatic lipase gene significantly modulates the HDL-cholesterol response to statin treatment. Atherosclerosis, 2005, Volume: 182, Issue:1 Topics: Aged; Anticholesteremic Agents; Cholesterol, HDL; Drug Resistance; Female; Humans; Hypercholesterolemia; Lipase; Male; Middle Aged; Polymorphism, Genetic; Pravastatin; Prospective Studies	2005

Article

Year

Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.

Clinical nephrology, 1995, Volume: 43, Issue:4

Topics: Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Female; Humans; Lipase; Lipoprotein Lipase; Lipoproteins; Lipoproteins, IDL; Liver; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Phosphatidylcholine-Sterol O-Acyltransferase; Pravastatin; Renal Dialysis; Triglycerides; Uremia

1995

The -514C/T polymorphism of the hepatic lipase gene significantly modulates the HDL-cholesterol response to statin treatment.

Atherosclerosis, 2005, Volume: 182, Issue:1

Topics: Aged; Anticholesteremic Agents; Cholesterol, HDL; Drug Resistance; Female; Humans; Hypercholesterolemia; Lipase; Male; Middle Aged; Polymorphism, Genetic; Pravastatin; Prospective Studies

2005

Other Studies

1 other study(ies) available for pravastatin and 1-anilino-8-naphthalenesulfonate

Article	Year
[The mechanism of action of hypolipidemic drugs]. Revue medicale de Liege, 1997, Volume: 52, Issue:6 Topics: Adipose Tissue; Anticholesteremic Agents; Cholesterol, LDL; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Lipase; Lipid Peroxidation; Lipoproteins, VLDL; Liver; Lovastatin; Microbodies; Nuclear Proteins; Pravastatin; Receptors, Cytoplasmic and Nuclear; Receptors, LDL; Simvastatin; Transcription Factors	1997

Article

Year

[The mechanism of action of hypolipidemic drugs].

Revue medicale de Liege, 1997, Volume: 52, Issue:6

Topics: Adipose Tissue; Anticholesteremic Agents; Cholesterol, LDL; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Lipase; Lipid Peroxidation; Lipoproteins, VLDL; Liver; Lovastatin; Microbodies; Nuclear Proteins; Pravastatin; Receptors, Cytoplasmic and Nuclear; Receptors, LDL; Simvastatin; Transcription Factors

1997